| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | QSR | Common Shares | Award | $90,907 | +1,393 | +4% | $65.26 | 36,215 | 28 Feb 2025 | Direct | F1, F2 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | QSR | Restricted Share Units | Award | $0 | +6,269 | $0.000000 | 6,269 | 28 Feb 2025 | Common Shares | 6,269 | Direct | F6, F12, F13 | ||
| transaction | QSR | Performance Share Units | Award | $0 | +23,008 | $0.000000 | 23,008 | 28 Mar 2025 | Common Shares | 23,008 | Direct | F14 | ||
| holding | QSR | Option (Right to Buy) | 60,000 | 28 Feb 2025 | Common Shares | 60,000 | $63.64 | Direct | F3, F4 | |||||
| holding | QSR | Option (Right to Buy) | 15,000 | 28 Feb 2025 | Common Shares | 15,000 | $66.31 | Direct | F4, F5 | |||||
| holding | QSR | Restricted Share Units | 3,108 | 28 Feb 2025 | Common Shares | 3,108 | Direct | F6, F7 | ||||||
| holding | QSR | Restricted Share Units | 4,737 | 28 Feb 2025 | Common Shares | 4,737 | Direct | F6, F8 | ||||||
| holding | QSR | Performance Share Units | 23,205 | 28 Feb 2025 | Common Shares | 23,205 | Direct | F9 | ||||||
| holding | QSR | Restricted Share Units | 7,446 | 28 Feb 2025 | Common Shares | 7,446 | Direct | F6, F10 | ||||||
| holding | QSR | Performance Share Units | 20,493 | 28 Feb 2025 | Common Shares | 20,493 | Direct | F11 |
| Id | Content |
|---|---|
| F1 | The shares reported represent common shares purchased from the Issuer by the Reporting Person upon exercise of his investment rights pursuant to the Issuer's 2024 Bonus Swap Program under its 2023 Omnibus Incentive Plan ("2023 Plan"). The Reporting Person elected to use 50% of his 2024 net bonus to purchase common shares at a purchase price of CAD$94.12 per share ("Investment Shares"). The purchase price was converted into its U.S. dollar equivalent using the Bank of Canada daily exchange rate on February 27, 2025. |
| F2 | Pursuant to the Issuer's 2023 Plan, the purchase price of the Investment Shares is calculated based on, the last sales prices of the common share of the Issuer on the Toronto Stock Exchange on the trading day immediately preceding the grant date, in this case February 27, 2025. |
| F3 | The options were issued with an exercise price of CAD $82.81. The reported exercise price represents the U.S. dollar equivalent. |
| F4 | These options are fully vested and exercisable. |
| F5 | The options were issued with an exercise price of CAD $88.03. The reported exercise price represents the U.S. dollar equivalent. |
| F6 | Each restricted share unit represents a contingent right to receive one common share. |
| F7 | These restricted share units vest in equal installments on December 31, 2022, December 31, 2023, December 31, 2024 and December 31, 2025. |
| F8 | These restricted share units vest in equal installments on December 15, 2023, December 15, 2024, December 15, 2025 and December 15, 2026. |
| F9 | The shares reported represent an award of performance based restricted share units ("2023 PBRSUs") granted to the Reporting Person. The 2023 PBRSUs will have a performance period beginning January 1, 2023 and ending December 31, 2025 and to the extent earned will vest on February 22, 2026, the number of common shares that will be earned at the end of the performance period is subject to increase or decrease based on the results of the performance condition. |
| F10 | These restricted share units vest in equal installments on December 15, 2024, December 15, 2025, December 15, 2026 and December 15, 2027. |
| F11 | The shares reported represent an award of performance based share units ("2024 PSUs") granted to the Reporting Person. The 2024 PSUs will have a performance period beginning February 23, 2024 and ending February 23, 2027 and to the extent earned will vest on March 15, 2027. The number of common shares that will be earned at the end of the performance period is subject to increase or decrease based on the results of the performance condition. |
| F12 | The Issuer granted the 2025 restricted share units ("2025 RSUs") to the Reporting Person pursuant to the Issuer's 2024 Bonus Swap Program under its 2023 Plan. The Reporting Person elected to use 50% of his 2024 net bonus to purchase Investment Shares and received a matching grant of 2025 RSUs in an amount equal to 50% of his gross bonus, multiplied by a multiple based on the Reporting Person's position level with the Issuer ("RSU Multiplier"), and divided by the purchase price of CAD$94.12 per share. The RSU Multiplier was 2.25 for executive vice presidents and above. If the Reporting Person sells any of the Investment Shares, he will forfeit all of the 2025 RSUs that have not yet vested. |
| F13 | These restricted share units vest in equal installments on December 15, 2025, December 15, 2026, December 15, 2027 and December 15, 2028. |
| F14 | The shares reported represent an award of performance based restricted share units ("2025 PBRSUs") granted to the Reporting Person. The 2025 PBRSUs have a performance period ending February 28, 2025 and ending February 28, 2028 and to the extent earned will vest on March 15, 2028. The number of common shares that will be earned at the end of the performance period is subject to increase or decrease based on the results of the performance condition. |